Cell Proliferation and Apoptosis—Key Players in the Lung Aging Process
Jesús Ancer-Rodríguez,Yareth Gopar-Cuevas,Karol García-Aguilar,María-de-Lourdes Chávez-Briones,Ivett Miranda-Maldonado,Adriana Ancer-Arellano,Marta Ortega-Martínez,Gilberto Jaramillo-Rangel
DOI: https://doi.org/10.3390/ijms25147867
IF: 5.6
2024-07-19
International Journal of Molecular Sciences
Abstract:Currently, the global lifespan has increased, resulting in a higher proportion of the population over 65 years. Changes that occur in the lung during aging increase the risk of developing acute and chronic lung diseases, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and lung cancer. During normal tissue homeostasis, cell proliferation and apoptosis create a dynamic balance that constitutes the physiological cell turnover. In basal conditions, the lungs have a low rate of cell turnover compared to other organs. During aging, changes in the rate of cell turnover in the lung are observed. In this work, we review the literature that evaluates the role of molecules involved in cell proliferation and apoptosis in lung aging and in the development of age-related lung diseases. The list of molecules that regulate cell proliferation, apoptosis, or both processes in lung aging includes TNC, FOXM1, DNA-PKcs, MicroRNAs, BCL-W, BCL-XL, TCF21, p16, NOX4, NRF2, MDM4, RPIA, DHEA, and MMP28. However, despite the studies carried out to date, the complete signaling pathways that regulate cell turnover in lung aging are still unknown. More research is needed to understand the changes that lead to the development of age-related lung diseases.
biochemistry & molecular biology,chemistry, multidisciplinary